09:41 AM EST, 02/27/2025 (MT Newswires) -- Dyne Therapeutics ( DYN ) shares were up 1.7% in early trading Thursday after the company reported a Q4 net loss of $0.88 per diluted share, compared with a $1.09 loss a year earlier.

Analysts polled by FactSet expected a $0.94 loss.

The company did not report revenue for the quarter ended Dec. 31.

The company said it had $642.3 million in cash, cash equivalents and marketable securities as of Dec. 31, which together with about $140.6 million in net proceeds from a recent at-the-market offering is expected to fund operations at least into H2 of 2026.

Price: 14.03, Change: +0.24, Percent Change: +1.74